Current vector control challenges in the fight against malaria

G Benelli, JC Beier - Acta tropica, 2017 - Elsevier
The effective and eco-friendly control of Anopheles vectors plays a key role in any malaria
management program. Integrated Vector Management (IVM) suggests making use of the full …

Ectoparasites: scabies

C Thomas, SJ Coates, D Engelman… - Journal of the American …, 2020 - Elsevier
Scabies is an ectoparasitic dermatosis caused by Sarcoptes scabiei var. hominis and is a
public health issue in all countries regardless of socioeconomic status. In high-income …

[HTML][HTML] Ivermectin and COVID-19: keeping rigor in times of urgency

C Chaccour, F Hammann… - The American journal …, 2020 - ncbi.nlm.nih.gov
Ivermectin is a widely used drug for the treatment and control of several neglected tropical
diseases. 1 The drug has an excellent safety profile, with more than 2.5 billion doses …

Antiviral effect of high-dose ivermectin in adults with COVID-19: a proof-of-concept randomized trial

A Krolewiecki, A Lifschitz, M Moragas, M Travacio… - …, 2021 - thelancet.com
Background There are limited antiviral options for the treatment of patients with COVID-19.
Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown …

The public health control of scabies: priorities for research and action

D Engelman, PT Cantey, M Marks, AW Solomon… - The Lancet, 2019 - thelancet.com
Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged
populations. The disease causes considerable morbidity and leads to severe bacterial …

Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS. NRIZ study) on the clearance of mild COVID‐19

H Elalfy, T Besheer, A El‐Mesery… - Journal of medical …, 2021 - Wiley Online Library
This trial compared the rate and time of viral clearance in subjects receiving a combination
of nitazoxanide, ribavirin, and ivermectin plus Zinc versus those receiving supportive …

Ivermectin: From theory to clinical application

DS Ashour - International journal of antimicrobial agents, 2019 - Elsevier
Approximately 250 million people have been using ivermectin (IVM) annually to combat
many parasitic diseases including filariasis, onchocerciasis, strongyloidiasis, scabies and …

[HTML][HTML] A roadmap for the development of ivermectin as a complementary malaria vector control tool

TI Roadmappers - The American journal of tropical medicine and …, 2020 - ncbi.nlm.nih.gov
In the context of stalling progress against malaria, resistance of mosquitoes to insecticides,
and residual transmission, mass drug administration (MDA) of ivermectin, an endectocide …

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers

J Muñoz, MR Ballester, RM Antonijoan… - PLoS neglected …, 2018 - journals.plos.org
Ivermectin is a pivotal drug for the control of onchocerciasis and lymphatic filariasis, which is
increasingly identified as a useful drug for the control of other Neglected Tropical Diseases …

A deadly embrace: Hemagglutination mediated by SARS-CoV-2 spike protein at its 22 N-glycosylation sites, red blood cell surface sialoglycoproteins, and antibody

DE Scheim - International journal of molecular sciences, 2022 - mdpi.com
Rouleaux (stacked clumps) of red blood cells (RBCs) observed in the blood of COVID-19
patients in three studies call attention to the properties of several enveloped virus strains …